GDS Enzymatic Salicylate Reagent
510(k) K882038
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK882038 | Date24 Jun 1988 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DKJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3830
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
This device is a colorimetry-based reagent for the detection of salicylate, as defined in the device type and nomenclature authority. It is used in clinical toxicology for the measurement of salicylate levels in patient specimens.
The reagent is supplied as an in vitro diagnostic product and is intended for use in laboratory settings. It is a single-use reagent, provided non-sterile, and requires storage under conditions specified by the manufacturer. The device received FDA 510(k) clearance (K882038) on June 24, 1988, and is classified as a Class II medical device under regulation number 862.3830.
Other devices from Gds Technology, LLC
Questions
AI-generated answers, 27 Sep 2026
What is the GDS Enzymatic Salicylate Reagent used for?
The GDS Enzymatic Salicylate Reagent is used in clinical toxicology for the measurement of salicylate levels in patient specimens, as it is a colorimetry-based reagent designed for this specific diagnostic purpose in laboratory settings.
How is the GDS Enzymatic Salicylate Reagent supplied and is it sterile?
The reagent is supplied as an in vitro diagnostic product in a non-sterile condition, intended for single-use in laboratory environments, and requires storage according to the manufacturer's specified conditions to maintain stability and performance.
What regulatory pathway was used for the GDS Enzymatic Salicylate Reagent?
The device received FDA 510(k) clearance under submission K882038 on June 24, 1988, and was determined to be substantially equivalent to a predicate device, which is the regulatory route for Class II medical devices like this one.